REGISTERED
on 18 Jun 2024
Last Applicant/ Owned by
GSK Medicines Research Centre
Stevenage
GB
SG12NY
Serial Number
97545134 filed on 11th Aug 2022
Registration Number
7417127 registered on 18th Jun 2024
Correspondent Address
Elizabeth K. Rucki
Filing Basis
1. intent to use
Disclaimer
NO DATA
LIBVYRA
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respira Read More
Classification Information
Class [005]
Pharmaceutical Products
Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97545134
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 84192968
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 18th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
| 02th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 13th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 22nd Feb 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 10th Jan 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| 29th Sep 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| 12th Jul 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 12th Jul 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |